Fulcrum Therapeutics, Inc. (FULC)

10.26 -0.34 (-3.21%) USD  |  NASDAQ  |  Jan 21, 13:34
More

Fulcrum Therapeutics Other Long Term Assets (Quarterly)

Other Long Term Assets (Quarterly) Chart

View Other Long Term Assets (Quarterly) for FULC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Other Long Term Assets (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Other Long Term Assets (Quarterly) Range, Past 5 Years

View Other Long Term Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Other Long Term Assets (Quarterly) Benchmarks

View Other Long Term Assets (Quarterly) Benchmarks
Start Trial
Agios Pharmaceuticals, Inc. Upgrade
Biogen, Inc. Upgrade
CorMedix, Inc. Upgrade
Apellis Pharmaceuticals, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade